---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047613"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T18:53:39.087958+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Evofem extends merger outside date with Aditxt to Jan 31, 2025

## Summary
- Fourth Amendment to Amended and Restated Merger Agreement dated Nov 19, 2024.
- Changes required consummation date from Nov 29, 2024 to Jan 31, 2025.
- Amendment modifies only Section 8.1(b)(ii); all other terms unchanged.

## SEC filing metadata
- accession: 0001493152-24-047613
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315224047613/0001493152-24-047613-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315224047613/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047613
- JSON: https://secwatch.observer/filing/0001493152-24-047613.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047613.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
